A

Arcutis Biotherapeutics
D

ARQT

10.760
USD
0.62
(6.11%)
مغلق
حجم التداول
52,922
الربح لكل سهم
0
العائد الربحي
-
P/E
-6
حجم السوق
1,259,399,799
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    B
    BLUE
    -0.04270
    (-11.74%)
    0.32090 USD
    B
    BNTX
    -3.740
    (-3.61%)
    99.740 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    E
    EDIT
    -0.11500
    (-4.14%)
    2.66500 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    R
    RARE
    -2.865
    (-6.02%)
    44.745 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    S
    SGMO
    -0.10000
    (-4.67%)
    2.04000 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    462.07 USD
    المزيد
الأخبار

العنوان: Arcutis Biotherapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.